| GABA-based therapeutic approaches: GABAA receptor subtype functions | Current Opinion in Pharmacology | 2006 | 379 |
| A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder | Proceedings of the National Academy of Sciences of the United States of America | 2006 | 124 |
| Kappa-opioid ligands in the study and treatment of mood disorders | Pharmacology & Therapeutics | 2009 | 114 |
| Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus | Neuroscience | 1997 | 112 |
| Plurality and resemblance in fMRI data analysis | NeuroImage | 1999 | 112 |
| THE INFLUENCE OF ACTINOMYCIN-D ON BRAIN RNA SYNTHESIS AND ON MEMORY | Journal of Neurochemistry | 1964 | 110 |
| Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates | Journal of Medicinal Chemistry | 2008 | 108 |
| Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests | Pain | 1998 | 107 |
| Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice | Pain | 2009 | 88 |
| A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization | Proceedings of the National Academy of Sciences of the United States of America | 1997 | 79 |
| Mutations in the dopamine β-hydroxylase gene are associated with human norepinephrine deficiency | American Journal of Medical Genetics Part A | 2002 | 76 |
| Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain | Brain Research | 1995 | 74 |
| Overexpression of HuD, but not of its truncated form HuD I+II, promotes GAP-43 gene expression and neurite outgrowth in PC12 cells in the absence of nerve growth factor | Journal of Neurochemistry | 2000 | 71 |
| Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use | American Journal on Addictions | 2006 | 68 |
| Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity | Biological Psychiatry | 2011 | 62 |
| Persistent reduction of immediate early gene mRNA in rat forebrain following single or multiple doses of cocaine | Molecular Brain Research | 1994 | 60 |
| Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice | Journal of Neuroscience Research | 2010 | 58 |
| Dynamics of phosphorylation and assembly of the high molecular weight neurofilament subunit in NB2a/d1 neuroblastoma | Journal of Neurochemistry | 1990 | 57 |
| Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18) | Bioorganic and Medicinal Chemistry Letters | 2006 | 56 |
| Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2) | Bioorganic and Medicinal Chemistry Letters | 2005 | 56 |
| Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study | Neuropsychopharmacology | 2009 | 53 |
| New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors | Bioorganic and Medicinal Chemistry | 2005 | 53 |
| Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression | Primary Care Companion To the Journal of Clinical Psychiatry | 2003 | 53 |
| Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues | Bioorganic and Medicinal Chemistry Letters | 2005 | 51 |
| Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats | Neuropsychopharmacology | 2008 | 49 |
